{
    "clinical_study": {
        "@rank": "124236", 
        "acronym": "ALMA", 
        "arm_group": {
            "arm_group_label": "Angioplasty of left main", 
            "description": "Patients with:\nstable or unstable angina and/or documented ischemia\nde novo \u226550% stenosis in the left main stem referred for angioplasty"
        }, 
        "brief_summary": {
            "textblock": "In patients with unprotected left main disease (ULMD), angioplasty is emerging as an\n      alternative technique. The investigators aimed to determine the rate of major cardiovascular\n      events in patients treated by angioplasty for ULMD in a \"real world\" registry."
        }, 
        "brief_title": "Angioplasty of Left Main - lAriboisiere Registry", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Coronary Artery Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "Current guidelines recommend coronary artery bypass graft surgery as the \"gold standard\"\n      treatment in patients with unprotected left main disease. However, patients with ULMD and\n      high surgical risk score or favourable anatomy are still referred for angioplasty. Recently,\n      several studies and registries comparing surgery and percutaneous intervention with drug\n      eluting stents report similar results regarding cardiovascular death and myocardial\n      infarction in patients with multivessel coronary artery disease including unprotected left\n      main disease.\n\n      The aim of the study is to evaluate major cardiovascular events in a \"real world\" registry."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  stable or unstable angina and/or documented ischemia\n\n          -  50% de novo ULMD referred for angioplasty\n\n        Exclusion Criteria:\n\n          -  acute coronary syndrome with ST elevation,\n\n          -  cardiogenic shock or out of hospital cardiac arrest"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Consecutive patients with stenosis of unprotected left main and schedulded angioplasty in\n        the Department of Cardiology, Lariboisiere Hospital."
            }
        }, 
        "enrollment": {
            "#text": "125", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 8, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01725373", 
            "org_study_id": "LRB-06-012"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "left main, stent,angioplasty", 
        "lastchanged_date": "January 12, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75010"
                }, 
                "name": "Departement of Cardiology, Laribosiere Hospital, APHP"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective Registry in Patients With Unprotected Left Main Disease Treated by Percutaneous Coronary Intervention: The ALMA (Angioplasty of Left Main - lAriboisiere) Registry", 
        "overall_official": {
            "affiliation": "Assistance Publique - H\u00f4pitaux de Paris", 
            "last_name": "Patrick Henry, MD-PhD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Major cardiovascular events (MACCE)were measured after 1 year follow-up. MACCE included all-cause of death, stroke, myocardial infarction, and repeat revascularizations. Non-Q-wave myocardial infarction was defined using universal definition with troponin I. Stent thrombosis was defined according to the Academic Research Consortium definition as definite, probable, or possible and as early or late after the index procedure. Repeat revascularization was composed of any repeat percutaneous intervention or surgical bypass.", 
            "measure": "Major cardiovascular events (MACCE)", 
            "safety_issue": "No", 
            "time_frame": "One year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01725373"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hopital Lariboisi\u00e8re", 
            "investigator_full_name": "Dr Jean-Guillaume DILLINGER", 
            "investigator_title": "Principal investigator - Medical Doctor in the Departement of Cardiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Hopital Lariboisi\u00e8re", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hopital Lariboisi\u00e8re", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2007", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}